UBS initiated coverage of ALX Oncology (ALXO) with a Buy rating and $6 price target The company has a potential blockbuster program with a CD47 combo currently in Phase II for metastatic breast cancer ...

The company expects to present full biomarker analysis from the Phase I/II evorpacept and zanidatamab trial at the ESMO Breast Conference in May 2026. Safety data from the ALX2004 dose escalation ...

From giant stick bugs to rarely seen sea creatures, these animal videos fascinated us—and led to new scientific discoveries. An orca calf and adult swim in the Norwegian fjords. Orcas have been among ...

With powerful video generation tools now in the hands of more people than ever, let's take a look at how they work. MIT Technology Review Explains: Let our writers untangle the complex, messy world of ...

JavaScript is a sprawling and ever-changing behemoth, and may be the single-most connective piece of web technology. From AI to functional programming, from the client to the server, here are nine ...

Ever wondered how JavaScript really works? In this video, we break down the computer science behind the world’s most popular programming language - from source code to execution? Learn how the engine ...

Ever wondered how JavaScript was created and how it became the world’s most popular programming language?From its early days in Netscape to powering modern web apps, servers, and beyond, this video ...

ALX ONCOLOGY ($ALXO) posted quarterly earnings results on Thursday, May 8th. The company reported earnings of -$0.58 per share, missing estimates of -$0.47 by $0.11 ...